|
    ACST Canada: TSX Venture

    Acasti Pharma Inc.

    ACSTCA
    Closed
    Back To Top
    Last Updated: Jul 26, 2021 3:59 p.m. EDT Delayed quote

    $ 0.58

    -0.02 -3.33%
    Previous Close
    $0.60
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 17.03K 65 Day Avg: 153.24K
    11% vs Avg
    0.58 Day Range 0.59
    0.22 52 Week Range 1.55

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ACST Overview

    Performance

    5 Day
    • -4.92%
    1 Month
    • -21.62%
    3 Month
    • -13.43%
    YTD
    • 38.10%
    1 Year
    • -34.83%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    • eLesor
    • Dow Jones

    No Headlines Available

    • Other News
    • Press Releases

    Stocks in play: Acasti Pharma Inc.

    on Baystreet.ca

    Stocks in play: Acasti Pharma Inc.

    on Baystreet.ca

    Acasti Pharma Inc.

    Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

    Competitors

    Name Chg % Market Cap
    Vitality Products Inc. 0.00% $7.87M
    Resverlogix Corp. -1.43% $167.28M
    Competitor Data Provided ByCapital Cube Logo